Merck Unveils Positive Phase 2 Results for Enpatoran, Showing Significant Reduction in Disease Activity in Patients with Cutaneous and Systemic Lupus with Active Rash Merck, a global leader in science…
Roche’s Genentech Faces Setback as FDA Advisory Committee Rejects Columvi Expansion Proposal The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) delivered a significant blow to Genentech,…
Celltrion’s YUFLYMA® Secures Full FDA Interchangeability Status Across All Approved Forms and Strengths, Reinforcing Market Leadership and Commitment to Affordable Biologics Celltrion, Inc., a global biopharmaceutical company headquartered in South…
Grifols Secures FDA Clearance to Advance Immunoglobulin Eye Drops into Phase 2 Trial for Dry Eye Disease Grifols, a global leader in the production of plasma-derived medicines and a prominent…
Charting a Healthier Future: A Comprehensive Analysis of Economic and Commercial Determinants of Health in Small Island Developing States A newly released technical paper by the World Health Organization (WHO)…
Alnylam Pharmaceuticals Unveils 2024 Corporate Responsibility Report, Showcasing Impact Across ESG Pillars Alnylam Pharmaceuticals, the industry leader in RNA interference (RNAi) therapeutics, has published its 2024 Corporate Responsibility Report, reaffirming…
BioNTech Strengthens Partnership with UK Government to Significantly Expand Regional Research and Development Efforts BioNTech , a leading biotechnology firm recognized globally for its pioneering work in mRNA technology and…
CRISPR Breakthrough in a Single Infant Sheds Light on the Urgent Crisis Facing Millions with Ultra-Rare Diseases A groundbreaking success story involving a custom-made CRISPR gene-editing therapy has given new…
Merck and imec Forge Strategic Alliance to Revolutionize Drug Discovery Through Advanced Microphysiological Systems Merck, a global leader in science and technology, and imec, a premier international hub for research…
Aetna Better Health of Illinois Invests $20.4 Million to Strengthen Value-Based Care and Improve Health Equity Across the State Aetna Better Health® of Illinois, a Medicaid managed care plan and…
Roche Provides Update on FDA Advisory Committee Review of Columvi Combination Therapy for Relapsed or Refractory DLBCL Roche has shared an important regulatory update concerning its investigational treatment for a…
FDA Grants Limited Approval to Novavax COVID-19 Vaccine Amid Signs of Upcoming Changes to Vaccine Approval Process The recent decision by the U.S. Food and Drug Administration (FDA) to grant…